HTA13 How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1473
https://www.valueinhealthjournal.com/article/S1098-3015(22)03678-6/fulltext
Title :
HTA13 How Health Technology Assessment Agencies View Clinical Evidence for Tumor Agnostic Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03678-6&doi=10.1016/j.jval.2022.09.1473
First page :
Section Title :
Open access? :
No
Section Order :
11014